CNS delivery of vectored prion-specific single-chain antibodies felays fisease onset

Molecular Therapy

Volumn 16, Issue 3, 2008, Pages 481-486

  Wuertzer, Charles A ^a   Sullivan, Mark A ^a   Qiu, Xing ^a   Federoff, Howard J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR; PRION PROTEIN SPECIFIC SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; RECOMBINANT ANTIBODY; RNA; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; HISTOPATHOLOGY; IN VIVO STUDY; INCUBATION TIME; MOUSE; NONHUMAN; PRION DISEASE; RNA TRANSLATION; ROTAROD TEST; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

MUS;

EID: 39849085645     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300387     Document Type: Article

References (24)

1. M Horiuchi B Caughey Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state EMBO J 18 1999 3193 3203
2. EM Sigurdsson DR Brown M Daniels RJ Kascsak R Kascsak R Carp Immunization delays the onset of prion disease in mice Am J Pathol 161 2002 13 17
3. A Schwarz O Krätke M Burwinkel C Riemer J Schultz P Henklein Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent Neurosci Lett 350 2003 187 189
4. FL Heppner C Musahl I Arrighi MA Klein T Rülicke B Oesch Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies Science 294 2001 178 182
5. AR White P Enever M Tayebi R Mushens J Linehan S Brandner Monoclonal antibodies inhibit prion replication and delay the development of prion disease Nature 422 2003 80 83
6. L Solforosi JR Criado DB McGavern S Wirz M Sánchez-Alavez S Sugama Cross-linking cellular prion protein triggers neuronal apoptosis in vivo Science 303 2004 1514 1516
7. M Enari E Flechsig C Weissmann Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody Proc Natl Acad Sci USA 98 2001 9295 9299
8. G Donofrio FL Heppner M Polymenidou C Musahl A Aguzzi Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies J Virol 79 2005 8330 8338
9. D Peretz RA Williamson K Kaneko J Vergara E Leclerc G Schmitt-Ulms Antibodies inhibit prion propagation and clear cell cultures of prion infectivity Nature 412 2001 739 743
10. J Malone MA Sullivan Analysis of antibody selection by phage display utilizing anti-phenobarbital antibodies J Mol Recognit 9 1996 738 745
11. TJ Vaughan AJ Williams K Pritchard JK Osbourn AR Pope JC Earnshaw Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library Nat Biotechnol 14 1996 309 314
12. M Hust S Dübel Phage display vectors for the in vitro generation of human antibody fragments Methods Mol Biol 295 2005 71 96
13. CG Haidaris J Malone LA Sherrill JM Bliss AA Gaspari RA Insel Recombinant human antibody single chain variable fragments reactive with Candida albicans surface antigens J Immunol Methods 257 2001 185 202
14. M Polymenidou FL Heppner EC Pellicioli E Urich G Miele N Braun Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection Proc Natl Acad Sci USA 101 suppl. 2 2004 14670 14676
15. PA McBride WJ Schulz-Schaeffer M Donaldson M Bruce H Diringer HA Kretzschmar Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves J Virol 75 2001 9320 9327
16. M Glatzel O Giger H Seeger A Aguzzi Variant Creutzfeldt-jakob disease: between lymphoid organs and brain Trends Microbiol 12 2004 51 53
17. X Feng FF Eide H Jiang AT Reder Adeno-associated viral vector-mediated ApoE expression in Alzheimer's disease mice: low CNS immune response, long-term expression, and astrocyte specificity Front Biosci 9 2004 1540 1546
18. SWJ McPhee CG Janson C Li RJ Samulski AS Camp J Francis Immune responses to AAV in a phase I study for Canavan disease J Gene Med 8 2006 577 588
19. PG Stevenson S Freeman CR Bangham S Hawke Virus dissemination through the brain parenchyma without immunologic control J Immunol 159 1997 1876 1884
20. PG Stevenson S Hawke DJ Sloan CR Bangham The immunogenicity of intracerebral virus infection depends on anatomical site J Virol 71 1997 145 151
21. JM Lecerf TL Shirley Q Zhu A Kazantsev P Amersdorfer DE Housman Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease Proc Natl Acad Sci USA 98 2001 4764 4769
22. MJ Coloma A Hastings LA Wims SL Morrison Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction J Immunol Methods 152 1992 89 104
23. AG Dickinson VM Meikle H Fraser Identification of a gene which controls the incubation period of some strains of scrapie agent in mice J Comp Pathol 78 1968 293 299
24. A Taraboulos K Jendroska D Serban SL Yang SJ DeArmond SB Prusiner Regional mapping of prion proteins in brain Proc Natl Acad Sci USA 89 1992 7620 7624